These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 21419164)

  • 1. Intranasal delivery of whole cell lysate of Mycobacterium tuberculosis induces protective immune responses to a modified live porcine reproductive and respiratory syndrome virus vaccine in pigs.
    Dwivedi V; Manickam C; Patterson R; Dodson K; Weeman M; Renukaradhya GJ
    Vaccine; 2011 May; 29(23):4067-76. PubMed ID: 21419164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-protective immunity to porcine reproductive and respiratory syndrome virus by intranasal delivery of a live virus vaccine with a potent adjuvant.
    Dwivedi V; Manickam C; Patterson R; Dodson K; Murtaugh M; Torrelles JB; Schlesinger LS; Renukaradhya GJ
    Vaccine; 2011 May; 29(23):4058-66. PubMed ID: 21419162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mycobacterium tuberculosis whole cell lysate enhances proliferation of CD8 positive lymphocytes and nitric oxide secretion in the lungs of live porcine respiratory and reproductive syndrome virus vaccinated pigs.
    Manickam C; Dwivedi V; Miller J; Papenfuss T; Renukaradhya GJ
    Viral Immunol; 2013 Feb; 26(1):102-8. PubMed ID: 23308386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative analysis of routes of immunization of a live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine in a heterologous virus challenge study.
    Ouyang K; Hiremath J; Binjawadagi B; Shyu DL; Dhakal S; Arcos J; Schleappi R; Holman L; Roof M; Torrelles JB; Renukaradhya GJ
    Vet Res; 2016 Mar; 47():45. PubMed ID: 26988085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranasal delivery of an adjuvanted modified live porcine reproductive and respiratory syndrome virus vaccine reduces ROS production.
    Binjawadagi B; Dwivedi V; Manickam C; Torrelles JB; Renukaradhya GJ
    Viral Immunol; 2011 Dec; 24(6):475-82. PubMed ID: 22111597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant Porcine Reproductive and Respiratory Syndrome Virus Expressing Membrane-Bound Interleukin-15 as an Immunomodulatory Adjuvant Enhances NK and γδ T Cell Responses and Confers Heterologous Protection.
    Cao QM; Ni YY; Cao D; Tian D; Yugo DM; Heffron CL; Overend C; Subramaniam S; Rogers AJ; Catanzaro N; LeRoith T; Roberts PC; Meng XJ
    J Virol; 2018 Jul; 92(13):. PubMed ID: 29643245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune responses and protection by vaccine and various vaccine adjuvant candidates to virulent porcine reproductive and respiratory syndrome virus.
    Charerntantanakul W; Platt R; Johnson W; Roof M; Vaughn E; Roth JA
    Vet Immunol Immunopathol; 2006 Jan; 109(1-2):99-115. PubMed ID: 16165219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An innovative approach to induce cross-protective immunity against porcine reproductive and respiratory syndrome virus in the lungs of pigs through adjuvanted nanotechnology-based vaccination.
    Binjawadagi B; Dwivedi V; Manickam C; Ouyang K; Torrelles JB; Renukaradhya GJ
    Int J Nanomedicine; 2014; 9():1519-35. PubMed ID: 24711701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive inductive effect of swine interleukin-4 on immune responses elicited by modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine.
    Peng J; Wang J; Wu J; Du Y; Li J; Guo Z; Yu J; Xu S; Zhang Y; Sun W; Cong X; Shi J
    Viral Immunol; 2013 Dec; 26(6):404-14. PubMed ID: 24328935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-mediated immune response and protective efficacy of porcine reproductive and respiratory syndrome virus modified-live vaccines against co-challenge with PRRSV-1 and PRRSV-2.
    Madapong A; Saeng-Chuto K; Boonsoongnern A; Tantituvanont A; Nilubol D
    Sci Rep; 2020 Feb; 10(1):1649. PubMed ID: 32015495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune response and protective efficacy of intramuscular and intradermal vaccination with porcine reproductive and respiratory syndrome virus 1 (PRRSV-1) modified live vaccine against highly pathogenic PRRSV-2 (HP-PRRSV-2) challenge, either alone or in combination with of PRRSV-1.
    Madapong A; Saeng-Chuto K; Chaikhumwang P; Tantituvanont A; Saardrak K; Pedrazuela Sanz R; Miranda Alvarez J; Nilubol D
    Vet Microbiol; 2020 May; 244():108655. PubMed ID: 32402335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PLGA nanoparticle entrapped killed porcine reproductive and respiratory syndrome virus vaccine helps in viral clearance in pigs.
    Dwivedi V; Manickam C; Binjawadagi B; Renukaradhya GJ
    Vet Microbiol; 2013 Sep; 166(1-2):47-58. PubMed ID: 23764272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Commercial porcine reproductive and respiratory syndrome virus (PRRSV)-2 modified live virus vaccine against heterologous single and dual Korean PRRSV-1 and PRRSV-2 challenge.
    Jeong J; Kim S; Park C; Park KH; Kang I; Park SJ; Chae C
    Vet Rec; 2018 Apr; 182(17):485. PubMed ID: 29472439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptide nanofiber hydrogel adjuvanted live virus vaccine enhances cross-protective immunity to porcine reproductive and respiratory syndrome virus.
    Li X; Galliher-Beckley A; Huang H; Sun X; Shi J
    Vaccine; 2013 Sep; 31(41):4508-15. PubMed ID: 23933333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Live porcine reproductive and respiratory syndrome virus vaccines: Current status and future direction.
    Renukaradhya GJ; Meng XJ; Calvert JG; Roof M; Lager KM
    Vaccine; 2015 Aug; 33(33):4069-80. PubMed ID: 26148878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of vaccination route (intradermal vs. intramuscular) against porcine reproductive and respiratory syndrome using a modified live vaccine on systemic and mucosal immune response and virus transmission in pigs.
    Renson P; Mahé S; Andraud M; Le Dimna M; Paboeuf F; Rose N; Bourry O
    BMC Vet Res; 2024 Jan; 20(1):5. PubMed ID: 38172908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of Fostera® PRRS modified live virus (MLV) vaccination strategy against a Thai highly pathogenic porcine reproductive and respiratory syndrome virus (HP-PRRSV) infection.
    Charoenchanikran P; Kedkovid R; Sirisereewan C; Woonwong Y; Arunorat J; Sitthichareonchai P; Sopipan N; Jittimanee S; Kesdangsakonwut S; Thanawongnuwech R
    Trop Anim Health Prod; 2016 Oct; 48(7):1351-9. PubMed ID: 27315207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of simultaneous vaccination with two modified live virus vaccines against porcine reproductive and respiratory syndrome virus types 1 and 2 in pigs.
    Kristensen CS; Kvisgaard LK; Pawlowski M; Holmgaard Carlsen S; Hjulsager CK; Heegaard PMH; Bøtner A; Stadejek T; Haugegaard S; Larsen LE
    Vaccine; 2018 Jan; 36(2):227-236. PubMed ID: 29191738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvanted poly(lactic-co-glycolic) acid nanoparticle-entrapped inactivated porcine reproductive and respiratory syndrome virus vaccine elicits cross-protective immune response in pigs.
    Binjawadagi B; Dwivedi V; Manickam C; Ouyang K; Wu Y; Lee LJ; Torrelles JB; Renukaradhya GJ
    Int J Nanomedicine; 2014; 9():679-94. PubMed ID: 24493925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut microbiome associations with outcome following co-infection with porcine reproductive and respiratory syndrome virus (PRRSV) and porcine circovirus type 2 (PCV2) in pigs immunized with a PRRS modified live virus vaccine.
    Constance LA; Thissen JB; Jaing CJ; McLoughlin KS; Rowland RRR; Serão NVL; Cino-Ozuna AG; Niederwerder MC
    Vet Microbiol; 2021 Mar; 254():109018. PubMed ID: 33639341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.